title: Updates from the 2014 San antonio breast cancer symposium.
abstract: The san antonio breast cancer syposium (SABCS 2014) was an exciting one this year. Data from the SOFT trial was presented that had potential implications on the treatment of pre menapausal women with hormone receptor positive breast cancer. In a phase II trial fulvestrant was found to significantly improve progression free and overall survival compared to anastrazole in the first line treatment of women with hormone receptor positive metastatic breast cancer. We saw a number of intersting abstracts looking at trying to refine the role of platinums and exploring the role of blocking PD-1 among women with triple receptor negative breast cancer. We also saw the results of a number of trials trying to refine standard chemotherapeutic regimens. Here we will review some fon the most interesting abstracts presented this year at SABCS 2014.
authors: Department of Medical Oncology, Dubai Hospital, Dubai Health Authority, United Arab Emirates.
authors: Shaheenah
authors: S
authors: Dawood
keywords: Breast cancer; ovarian suppression; targeted therapy; triple negative